Transcranial magnetic stimulation, offered at select locations, provides a noninvasive neuromodulation option for certain mood disorders. Spravato® treatment is also available for patients who meet clinical criteria and need an alternative to standard antidepressant approaches. These services extend the therapeutic range of the clinics beyond routine psychiatric care, creating a more flexible treatment environment for resistant or difficult-to-treat conditions.

Counseling and ongoing psychiatric medication oversight are integrated alongside these advanced therapies, reinforcing a care model that is both structured and adaptive. The emphasis is not simply on introducing specialized treatments, but on placing them within a broader plan designed to improve day-to-day functioning as well as symptom burden. This makes the practice particularly aligned with patients who require coordinated support across psychotherapy, medication, and newer biological interventions.

Access is also part of the model. Participation with most major health insurance plans helps support availability of care across the group’s Los Angeles-area clinics, allowing patients to engage with treatment in settings that are connected by a shared clinical approach. The overall profile is that of a modern psychiatric practice that blends mainstream psychiatric care with targeted, rapid-acting, and neuromodulation-based options when clinically appropriate.